par Pandolfo, Massimo 
;Arpa, Javier;Delatycki, Martin B;Le Quan Sang, Kim Hanh;Mariotti, Caterina;Munnich, Arnold;Sanz-Gallego, Irene;Tai, Geneieve;Tarnopolsky, Mark A;Taroni, Franco;Spino, Michael;Tricta, Fernando
Référence Annals of neurology, 76, 4, page (509-521)
Publication Publié, 2014-08
;Arpa, Javier;Delatycki, Martin B;Le Quan Sang, Kim Hanh;Mariotti, Caterina;Munnich, Arnold;Sanz-Gallego, Irene;Tai, Geneieve;Tarnopolsky, Mark A;Taroni, Franco;Spino, Michael;Tricta, FernandoRéférence Annals of neurology, 76, 4, page (509-521)
Publication Publié, 2014-08
Article révisé par les pairs
| Résumé : | We conducted a 6-month, randomized, double-blind, placebo-controlled study to assess safety, tolerability, and efficacy of deferiprone in Friedreich ataxia (FRDA). |
